Researchers have identified a rare population of potentially toxic senescent cells that may be a novel target for Alzheimer's disease therapies.
Researchers recorded alterations in levels of both dopamine and serotonin in the brain when people perform perception and decision making based tasks.
Following the Mediterranean ketogenic diet can help modulate unique fungi found in the gut of those with mild cognitive impairment.
A modified Mediterranean-ketogenic diet can modulate the gut microbiome and metabolites associated with improvements in Alzheimer's disease biomarkers.
Older adults with mild cognitive impairment who practiced mindful meditation for 20 minutes a day were more likely to have an understanding of the underlying concepts of mindfulness. The study demonstrates memory impairments associated with MCI do not preclude learning mindfulness skills.
Neuroimaging reveals a significantly diminished response in the ventromedial prefrontal cortex in children on the autism spectrum. The findings could be used as a biomarker for diagnosing ASD.
Researchers have developed a probiotic 'cocktail' from gut bacteria found in infant feces. They say the 'cocktail' could help to increase the body's ability to produce short chain fatty acids. The probiotic could be used to help those suffering from cancers, autoimmune disorders, obesity, diabetes and other disorders which limit the ability of the body to produce SCFAs naturally.
There is new hope for people suffering from memory related problems. Researchers have successfully implanted a neuroprosthetic system into the brains of epilepsy patients that uses the person's own memory patterns to enhance memory encoding and recall.